AQST Aquestive Corp: Accounting Value per Share

Graphic logo of Aquestive Therapeutics (AQST)

Aquestive Therapeutics (AQST) utilizes the PharmFilm platform to convert conventional tablets into soluble films, which streamlines the launch of new products; this price chart is currently at the -0.45 level. The primary threats lie in potential regulatory rejections and fierce competition from traditional drug formats. Meanwhile, patents provide certain pricing power despite demands from insurance companies to lower prices.

Aquestive Therapeutics Inc (AQST): Share Book Value from 07/04/2022 to 10/28/2026
Manufactured products of Aquestive Therapeutics, Inc.

Book value per share reflects the portion of equity attributable to a single security after all liabilities are settled. The calculation algorithm accounts for profit reinvestment and share buybacks between quarterly reports. By analyzing the equity per common share chart, an investor can see the real value of net assets. For Aquestive Therapeutics (AQST), this indicator confirms financial stability during the commercialization of adrenaline films. The trend of this metric depends directly on patent protection and FDA approvals.

Competitors of Aquestive Therapeutics (AQST)

Net Assets per Single Share HLN (Haleon Group)|Kenvue Health (KVUE) - Net Assets per Share|VRNA - Accounting Value per Share|MENS (jyongbio.com) - Book Price of a Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Book Value per Share QNTM (Quantum BioPharma)|FibroGen Inc - Book Value per Share|Net Assets per Single Share TELO|Rani Therapeutics (RANI) - Book Value of One Share|SNYR: Accounting Value per Share|Rallybio (RLYB) - Book Value per Share|Book Value per Share LEXX (Lexaria Bioscience Corp)|Net Asset Value per Share PULM|PTHL (Pheton Holdings Ltd) - Net Assets per Single Share|Net Assets per Share aptorumgroup.com APM|Accounting Value per Share Lyra Therapeutics, Inc. (LYRA)|Book Price of a Share Impact BioMedical, Inc. IBO|Book Value per Share TNFA (TNF Pharma)|cbdMD, Inc. (YCBD) - Net Assets per Share|PainReform Limited (PRFX) - Accounting Value per Share|Altamira Therapeutics Ltd. (CYTO) - Net Assets per Single Share|Book Value per Share LIPO (Lipella Pharmaceuticals)|Net Asset Value per Share optinose.com (OPTN)|Pieris Pharmaceuticals, Inc. (PIRS) - Accounting Value per Share|Accounting Value of a Share Procaps Group PROC|Accounting Value per Share Petros (PTPI)|Book Price of a Share Qilian International Corp QLI|Book Value per Share Acelyrin, Inc. (SLRN)|TFFP - Accounting Value of a Share